At last,Genentech

Genentech(DNA) has reported strong fourth quarter earnings and projected a good 2007.It's been a long wait,but the good feelings investors got made it worth it.They were vindicated.Even more important to them is the benefit that patients got from DNA's drugs.Investors helped to make it possible.Since the earnings were reported,the stock has continued to climb out of the funk it had been in for so long.Good earnings are good medicine.